Math is precise, but doesn’t make it accurate. Formulas health economists use calculate a drug’s value rely on uncertain human inputs. @SpeakerPelosi, don’t import this math from Europe. Errors can brand a drug as “not worth it” even when it is. Help patients by fixing insurance.
https://twitter.com/peterneumann11/status/1415666914551083009
I’m not saying that one can’t attempt to appreciate how much value a drug generates for society. I’m saying that one should be very careful about math that attempts to override the market to set prices. The math can and should be improved. Here’s how. global-uploads.webflow.com/606ac6e3ee6c27…
And if you are curious about why price controls based on bad math would kill innovation, here’s a step by step explainer of the murdering process. nopatientleftbehind.docsend.com/view/b65fjkcdi…
Solution to affordability is to reform insurance by lowering out of costs. Why is there even a copay for cancer drugs or insulin or a medicine to treat depression or osteoporosis? Who fakes those things to get those drugs? No one.
Congress already outlawed discrimination by insurance against patients based on their pre-existing condition. OOP costs are just discrimination against patients’ emergent conditions. Outlaw them! OOP should stand for “out-of-premium”. nopatientleftbehind.org
• • •
Missing some Tweet in this thread? You can try to
force a refresh
